1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key Benefits for the Stakeholder
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Processes
3. EXECUTIVE SUMMARY
3.1. Key Findings
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. BLOOD GLUCOSE TEST STRIPS MARKET BY DIABETES TYPE
5.1. Introduction
5.2. Type I Diabetes
5.3. Type II Diabetes
6. BLOOD GLUCOSE TEST STRIPS MARKET BY DISTRIBUTION CHANNEL
6.1. Introduction
6.2. Online
6.3. Offline
7. BLOOD GLUCOSE TEST STRIPS MARKET BY END-USER
7.1. Introduction
7.2. Hospitals and Clinics
7.3. Ambulatory Surgery Centers
7.4. Diagnostic Centers
8. BLOOD GLUCOSE TEST STRIPS MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. United States
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. UK
8.4.4. Italy
8.4.5. Spain
8.4.6. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Israel
8.5.4. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. Australia
8.6.3. Japan
8.6.4. South Korea
8.6.5. India
8.6.6. Thailand
8.6.7. Taiwan
8.6.8. Indonesia
8.6.9. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Abbott Diabetes Care
10.2. F. Hoffmann-La Roche Ltd
10.3. AgaMatrix, Inc.
10.4. Bayer
10.5. LifeScan IP Holdings, LLC
10.6. Care Touch USA
10.7. GenUltimate!
10.8. Arkray Inc
10.9. Metene
10.10. Medtronic